Coronavirus India Live Updates: New Covid-19 Strain Latest News, Covid-19 Vaccine, Coronavirus Cases in India Today Update–INDIAN EXPRESS

Clipped from:

Coronavirus (Covid-19) India Live News Updates: There are 2.89 lakh active cases in the country, while as many as 96.63 lakh people have recovered from the disease.

Coronavirus India Live Updates: As many as 1,688 passengers arrived at the Mumbai international airport from the UK and other countries since Monday midnight and 745 of them were quarantined in the city, news agency PTI reported. In the wake of detection of a new variant of coronavirus in the UK, a new Standard Operating Procedure has been issued for dealing with passengers arriving from Europe and the Middle-East. BMC teams at the airport are exempting from quarantine
some categories of passengers such as pregnant women or those traveling to attend the last rites of their kin, the official said. So far two passengers have been exempted.

Karnataka government on Wednesday revised the night curfew timings and date amid fears of new and fast-spreading Covid-19 strain in the UK. Chief Minister B S Yediyurappa in a series of tweets said that the night curfew, which is intended to be enforced from today, will go into effect tomorrow, 24 December from 11 pm to 5 am and will continue till 2 January, 5 am.

India reported 23,950 new Covid-19 cases on Wednesday, taking the total tally of coronavirus cases in the country to 1,00,99,066, according to data from the Union Health Ministry. With 333 fatalities in the last 24 hours, the death toll touched 1,46,444. There are 2.89 lakh active cases in the country, while as many as 96.63 lakh people have recovered from the disease.

Rajasthan has become the tenth state to record over three lakh confirmed coronavirus cases. Meanwhile, the Centre on Tuesday assured that there is no reason for panic, noting that the new strain of the novel coronavirus being detected in the United Kingdom has not been seen in India.

Night curfew in place in Pune on Tuesday. (Express photo by Ashish Kale)

Just two weeks after the expert committee scrutinising applications for emergency use authorisation (EUA) of Pune-based Serum Institute of India’s Covid-19 vaccine sought additional late-stage safety and efficacy data, the firm has submitted fresh data to the regulator, government sources said.

“Serum Institute India has submitted additional data. The regulator’s office, internally, will review these documents. Only then they will request the Subject Expert Committee (SEC) to meet,” sources told The Indian Express.

Significantly, the media has reported that the UK regulator is set to “clear” the Oxford-AstraZeneca vaccine, “possibly on December 28 and December 29”. In India, SII which sought EUA from the Drugs Controller General of India (DGCI) on December 10 was asked to submit safety data on Phase 2/3 clinical trials in India of its vaccine candidate named Covishield, developed by Oxford-AstraZeneca.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s